UUU Form 4: 50,000 CEO options vest 10/20/25; exercise after NYSE OK

Rhea-AI Filing Summary

Universal Safety Products (UUU) reported an insider equity award. Chairman, President and CEO (also a Director) Harvey B. Grossblatt reported the acquisition of 50,000 stock options on 10/20/2025 at an exercise price of $3.4 per share, recorded on a Form 4 with transaction code A (grant).

The options were originally granted on August 27, 2025 subject to stockholder approval and vested on October 20, 2025, the date stockholders approved them. They become exercisable after NYSE American approves the supplemental listing application for the underlying common shares. The award covers 50,000 shares of common stock, carries a stated price of $0 for the derivative grant, and has an expiration date of 08/26/2035. Following the reported transaction, 50,000 derivative securities are beneficially owned, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GROSSBLATT HARVEY B

(Last) (First) (Middle)

11407 CRONHILL DRIVE, SUITE A

(Street)

OWINGS MILLS MD 21117

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL SAFETY PRODUCTS, INC. [ UUU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$3.4	10/20/2025		A		50,000(1)		(2)	08/26/2035	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. The stock options (the "Options") were granted on August 27, 2025, subject to stockholder approval. The Options vested on October 20, 2025, the date of stockholder approval.

2. The Options are exercisable as soon as the NYSE American approves the supplemental listing application relating to the issuance of the common stock underlying the Options.

	By: /s/ Harvey B. Grossblatt	10/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did UUU report on Form 4?

An award of 50,000 stock options to Chairman, President and CEO Harvey B. Grossblatt, recorded as an A (grant) on 10/20/2025.

What is the exercise price and term of the options for UUU?

The options have an exercise price of $3.4 per share and an expiration date of 08/26/2035.

When did the UUU options vest and when were they granted?

They were granted on August 27, 2025 (subject to stockholder approval) and vested on October 20, 2025 upon approval.

When can the UUU options be exercised?

They are exercisable after NYSE American approves the supplemental listing application for the underlying shares.

How many shares underlie the reported options for UUU?

The options are for 50,000 shares of common stock.

What is the post-transaction ownership reported?

Following the transaction, 50,000 derivative securities are beneficially owned, held directly.

Who is the reporting person in UUU’s filing?

The filing is signed by Harvey B. Grossblatt, who is Chairman, President and CEO and a Director.